Your browser doesn't support javascript.
loading
The enduring gap in educational attainment in schizophrenia according to the past 50 years of published research: a systematic review and meta-analysis.
Crossley, Nicolás A; Alliende, Luz María; Czepielewski, Leticia S; Aceituno, David; Castañeda, Carmen Paz; Diaz, Camila; Iruretagoyena, Barbara; Mena, Carlos; Mena, Cristian; Ramirez-Mahaluf, Juan Pablo; Tepper, Angeles; Vasquez, Javiera; Fonseca, Lais; Machado, Viviane; Hernández, Camilo E; Vargas-Upegui, Cristian; Gomez-Cruz, Gladys; Kobayashi-Romero, Luis F; Moncada-Habib, Tomas; Arango, Celso; Barch, Deanna M; Carter, Cameron; Correll, Christoph U; Freimer, Nelson B; McGuire, Philip; Evans-Lacko, Sara; Undurraga, Eduardo; Bressan, Rodrigo; Gama, Clarissa S; Lopez-Jaramillo, Carlos; de la Fuente-Sandoval, Camilo; Gonzalez-Valderrama, Alfonso; Undurraga, Juan; Gadelha, Ary.
Afiliación
  • Crossley NA; Department of Psychiatry, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile; Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK. Electronic address: ncrossley@uc.cl.
  • Alliende LM; Department of Psychiatry, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile; Department of Psychiatry and Behavioral Neuroscience, School of Medicine, The University of Chicago, Chicago, IL, USA.
  • Czepielewski LS; Laboratory of Molecular Psychiatry, Centro de Pesquisa Clínica, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil; Programa de Pós-Graduação em Psicologia, Instituto Psicologia, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Brazil.
  • Aceituno D; Psychiatry and Mental Health Service, Complejo Asistencial Dr Sótero del Río, Puente Alto, Chile.
  • Castañeda CP; Early Intervention Program, Instituto Psiquiátrico Dr. J. Horwitz Barak, Santiago, Chile.
  • Diaz C; Pharmacovigilance Program, Instituto Psiquiátrico Dr. J. Horwitz Barak, Santiago, Chile.
  • Iruretagoyena B; Department of Psychiatry, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile; Department of Neurology and Psychiatry, Faculty of Medicine, Clínica Alemana Universidad del Desarrollo, Vitacura, Chile.
  • Mena C; Department of Psychiatry, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile; Institute of Cognitive Neuroscience, University College London, London, UK.
  • Mena C; Early Intervention Program, Instituto Psiquiátrico Dr. J. Horwitz Barak, Santiago, Chile; School of Medicine, Universidad Finis Terrae, Santiago, Chile.
  • Ramirez-Mahaluf JP; Department of Psychiatry, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Tepper A; Department of Psychiatry, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Vasquez J; Department of Psychiatry, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Fonseca L; Schizophrenia Program (PROESQ), Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil.
  • Machado V; Schizophrenia Program (PROESQ), Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil; Interdisciplinary Laboratory in Clinical Neuroscience (LiNC), Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil.
  • Hernández CE; Department of Psychiatry, Faculty of Medicine, University of Antioquia, Medellín, Colombia.
  • Vargas-Upegui C; Department of Psychiatry, Faculty of Medicine, University of Antioquia, Medellín, Colombia.
  • Gomez-Cruz G; Laboratory of Experimental Psychiatry, Instituto Nacional de Neurología y Neurocirugía, Mexico City, Mexico.
  • Kobayashi-Romero LF; Laboratory of Experimental Psychiatry, Instituto Nacional de Neurología y Neurocirugía, Mexico City, Mexico.
  • Moncada-Habib T; Laboratory of Experimental Psychiatry, Instituto Nacional de Neurología y Neurocirugía, Mexico City, Mexico.
  • Arango C; Department of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón, School of Medicine, Universidad Complutense, CIBERSAM, Madrid, Spain.
  • Barch DM; School of Medicine, University of Washington in St Louis, St Louis, MO, USA.
  • Carter C; Department of Psychiatry and Behavioral Sciences, University of California Davis, Davis, CA, USA.
  • Correll CU; Department of Psychiatry, The Zucker Hillside Hospital, Northwell Health, Glen Oaks, NY, USA; Department of Psychiatry and Molecular Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA; Department of Child and Adolescent Psychiatry, Charité Universitätsmed
  • Freimer NB; Center for Neurobehavioral Genetics, Jane and Terry Semel Institute for Neuroscience and Human Los Angeles, CA, USA.
  • McGuire P; Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
  • Evans-Lacko S; Care Policy and Evaluation Centre, London School of Economics and Political Science, London, UK.
  • Undurraga E; School of Government, Pontificia Universidad Católica de Chile, Santiago, Chile; Research Center for Integrated Disaster Risk Management (CIGIDEN), Santiago, Chile; CIFAR Azrieli Global Scholars Program, CIFAR, Toronto, ON, Canada.
  • Bressan R; Interdisciplinary Laboratory in Clinical Neuroscience (LiNC), Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil.
  • Gama CS; Laboratory of Molecular Psychiatry, Centro de Pesquisa Clínica, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil; Graduate Program in Psychiatry and Behavioral Sciences, Departamento de Psiquiatria e Medicina Legal, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Brazil.
  • Lopez-Jaramillo C; Department of Psychiatry, Faculty of Medicine, University of Antioquia, Medellín, Colombia.
  • de la Fuente-Sandoval C; Laboratory of Experimental Psychiatry, Instituto Nacional de Neurología y Neurocirugía, Mexico City, Mexico.
  • Gonzalez-Valderrama A; Early Intervention Program, Instituto Psiquiátrico Dr. J. Horwitz Barak, Santiago, Chile; School of Medicine, Universidad Finis Terrae, Santiago, Chile.
  • Undurraga J; Early Intervention Program, Instituto Psiquiátrico Dr. J. Horwitz Barak, Santiago, Chile; Department of Neurology and Psychiatry, Faculty of Medicine, Clínica Alemana Universidad del Desarrollo, Vitacura, Chile.
  • Gadelha A; Schizophrenia Program (PROESQ), Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil; Interdisciplinary Laboratory in Clinical Neuroscience (LiNC), Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil.
Lancet Psychiatry ; 9(7): 565-573, 2022 07.
Article en En | MEDLINE | ID: mdl-35717966
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trastornos Psicóticos / Esquizofrenia Tipo de estudio: Guideline / Prognostic_studies / Systematic_reviews Límite: Adolescent / Female / Humans / Male Idioma: En Revista: Lancet Psychiatry Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trastornos Psicóticos / Esquizofrenia Tipo de estudio: Guideline / Prognostic_studies / Systematic_reviews Límite: Adolescent / Female / Humans / Male Idioma: En Revista: Lancet Psychiatry Año: 2022 Tipo del documento: Article